Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dror Marchaim

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|March 10, 2010
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health systemTara Reddy, Teena Chopra, Dror Marchaim, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 12, 2026
Community-onset symptomatic urinary tract infections (SUTI) caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: independent predictors and comparative effectiveness of oral agentsShani Zilberman-Itskovich, Majdi Masarwi, Eyal Levy, et al.
Infection Control and Hospital Epidemiology|July 1, 2010
Observer bias in hand hygiene compliance reportingSorabh Dhar, Ryan Tansek, Elizabeth A Toftey, et al.
Infection Control and Hospital Epidemiology|March 8, 2014
Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilitiesAshish Bhargava, Kayoko Hayakawa, Ethan Silverman, et al.
American Journal of Infection Control|May 20, 2014
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysisChristopher Bogan, Keith S Kaye, Teena Chopra, et al.
Open Forum Infectious Diseases|December 27, 2016
Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant OrganismsGil Marcus, Samuel Levy, Ghaleb Salhab, et al.
Annals of Clinical Microbiology and Antimicrobials|June 5, 2015
Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant EnterobacteriaceaeViolet Leibman, Emily T Martin, Ruthy Tal-Jasper, et al.
The American Journal of Cardiology|July 25, 2018
Usefulness of Serum Procalcitonin as a Markerfor Coexisting Infection in Patients With Acute Myocardial InfarctionItzhak Vitkon-Barkay, Tsilia Lazarovitch, Dror Marchaim, et al.
Infection Control and Hospital Epidemiology|July 5, 2012
Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory testsDror Marchaim, Bharath Sunkara, Paul R Lephart, et al.
American Journal of Infection Control|May 3, 2015
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepimeTeena Chopra, Dror Marchaim, Paul C Johnson, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|March 10, 2010
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health systemTara Reddy, Teena Chopra, Dror Marchaim, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 12, 2026
Community-onset symptomatic urinary tract infections (SUTI) caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: independent predictors and comparative effectiveness of oral agentsShani Zilberman-Itskovich, Majdi Masarwi, Eyal Levy, et al.
Infection Control and Hospital Epidemiology|July 1, 2010
Observer bias in hand hygiene compliance reportingSorabh Dhar, Ryan Tansek, Elizabeth A Toftey, et al.
Infection Control and Hospital Epidemiology|March 8, 2014
Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilitiesAshish Bhargava, Kayoko Hayakawa, Ethan Silverman, et al.
American Journal of Infection Control|May 20, 2014
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysisChristopher Bogan, Keith S Kaye, Teena Chopra, et al.
Open Forum Infectious Diseases|December 27, 2016
Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant OrganismsGil Marcus, Samuel Levy, Ghaleb Salhab, et al.
Annals of Clinical Microbiology and Antimicrobials|June 5, 2015
Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant EnterobacteriaceaeViolet Leibman, Emily T Martin, Ruthy Tal-Jasper, et al.
The American Journal of Cardiology|July 25, 2018
Usefulness of Serum Procalcitonin as a Markerfor Coexisting Infection in Patients With Acute Myocardial InfarctionItzhak Vitkon-Barkay, Tsilia Lazarovitch, Dror Marchaim, et al.
Infection Control and Hospital Epidemiology|July 5, 2012
Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory testsDror Marchaim, Bharath Sunkara, Paul R Lephart, et al.
American Journal of Infection Control|May 3, 2015
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepimeTeena Chopra, Dror Marchaim, Paul C Johnson, et al.
Pageof 11